PROS1 and COVID-19: The commercially approved COVID-19 vaccines and many of the COVID-19 vaccine candidates currently under development are derived from the first available SARS-CoV-2 S-protein angiotensin converting enzyme-2 (ACE-2) receptor sequences of Wuhan genome NC045512.2 [10,11].